MktsMarkets

NovoCure Limited
NASDAQ: NVCRKey statistics
NVCR News
Stories mentioning NVCR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 174,055 | 174,350 | 167,204 | 158,805 | 154,994 | 161,266 | 155,095 | 150,356 |
| Cost of Goods Sold | 38,929 | 42,157 | 44,729 | 41,472 | 38,521 | 33,466 | 35,372 | 34,654 |
| Gross Profit | 135,126 | 132,193 | 122,475 | 117,333 | 116,473 | 127,800 | 119,723 | 115,702 |
| Operating Expenses | ||||||||
| Research & Development | 58,336 | 60,905 | 54,029 | 55,833 | 53,777 | 51,210 | 51,882 | 54,955 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 202,546 | 172,586 | 158,496 | 156,854 | 154,338 | 191,104 | 151,815 | 149,282 |
| Operating Income (Loss) | (67,420) | (40,393) | (36,021) | (39,521) | (37,865) | (63,304) | (32,092) | (33,580) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (69,258) | (40,954) | (30,022) | (34,979) | (30,295) | (55,206) | (21,585) | (22,729) |
| Tax Provision | 1,880 | (16,455) | 7,248 | 5,160 | 4,024 | 10,716 | 8,985 | 10,646 |
| Net Income (Loss) | (71,138) | (24,499) | (37,270) | (40,139) | (34,319) | (65,922) | (30,570) | (33,375) |
| Earnings Per Share (Basic) | (0.62) | (0.22) | (0.33) | (0.36) | (0.31) | (0.61) | (0.28) | (0.31) |
| Earnings Per Share (Diluted) | (0.62) | (0.22) | (0.33) | (0.36) | (0.31) | (0.61) | (0.28) | (0.31) |
| Weighted Average Shares Outstanding (Basic) | 114,150 | 111,472 | 111,908 | 111,572 | 110,282 | 107,834 | 108,248 | 107,700 |
| Weighted Average Shares Outstanding (Diluted) | 114,150 | 111,472 | 111,908 | 111,572 | 110,282 | 107,834 | 108,248 | 107,700 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NVCR
NovoCure Limited (NASDAQ: NVCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol NVCR. It last traded at $13.10 (Oct 30, 2026, 12:32 PM ET), down 0.1% on the day. That gives NovoCure a market capitalisation of $1.6B.
Over the past 52 weeks NVCR has traded between $9.82 and $21.45.
Revenue for the quarter ended Mar 31, 2026 was $174.1M; a net loss of $71.1M. Revenue was up 12.3% from $155.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $174.1M | -$71.1M | -40.9% |
| Dec 31, 2025 | $174.4M | -$24.5M | -14.1% |
| Sep 30, 2025 | $167.2M | -$37.3M | -22.3% |
| Jun 30, 2025 | $158.8M | -$40.1M | -25.3% |
From NovoCure’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…